Literature DB >> 24200957

Irritable bowel syndrome-diarrhea: characterization of genotype by exome sequencing, and phenotypes of bile acid synthesis and colonic transit.

Michael Camilleri1, Eric W Klee, Andrea Shin, Paula Carlson, Ying Li, Madhusudan Grover, Alan R Zinsmeister.   

Abstract

The study objectives were: to mine the complete exome to identify putative rare single nucleotide variants (SNVs) associated with irritable bowel syndrome (IBS)-diarrhea (IBS-D) phenotype, to assess genes that regulate bile acids in IBS-D, and to explore univariate associations of SNVs with symptom phenotype and quantitative traits in an independent IBS cohort. Using principal components analysis, we identified two groups of IBS-D (n = 16) with increased fecal bile acids: rapid colonic transit or high bile acids synthesis. DNA was sequenced in depth, analyzing SNVs in bile acid genes (ASBT, FXR, OSTα/β, FGF19, FGFR4, KLB, SHP, CYP7A1, LRH-1, and FABP6). Exome findings were compared with those of 50 similar ethnicity controls. We assessed univariate associations of each SNV with quantitative traits and a principal components analysis and associations between SNVs in KLB and FGFR4 and symptom phenotype in 405 IBS, 228 controls and colonic transit in 70 IBS-D, 71 IBS-constipation. Mining the complete exome did not reveal significant associations with IBS-D over controls. There were 54 SNVs in 10 of 11 bile acid-regulating genes, with no SNVs in FGF19; 15 nonsynonymous SNVs were identified in similar proportions of IBS-D and controls. Variations in KLB (rs1015450, downstream) and FGFR4 [rs434434 (intronic), rs1966265, and rs351855 (nonsynonymous)] were associated with colonic transit (rs1966265; P = 0.043), fecal bile acids (rs1015450; P = 0.064), and principal components analysis groups (all 3 FGFR4 SNVs; P < 0.05). In the 633-person cohort, FGFR4 rs434434 was associated with symptom phenotype (P = 0.027) and rs1966265 with 24-h colonic transit (P = 0.066). Thus exome sequencing identified additional variants in KLB and FGFR4 associated with bile acids or colonic transit in IBS-D.

Entities:  

Keywords:  klotho B; risk factor; susceptibility; symptom

Mesh:

Substances:

Year:  2013        PMID: 24200957      PMCID: PMC3920085          DOI: 10.1152/ajpgi.00294.2013

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  43 in total

1.  Predicting deleterious amino acid substitutions.

Authors:  P C Ng; S Henikoff
Journal:  Genome Res       Date:  2001-05       Impact factor: 9.043

2.  Analysis of ileal sodium/bile acid cotransporter and related nuclear receptor genes in a family with multiple cases of idiopathic bile acid malabsorption.

Authors:  Marco Montagnani; Anna Abrahamsson; Cecilia Gälman; Gösta Eggertsen; Hanns-Ulrich Marschall; Elisa Ravaioli; Curt Einarsson; Paul A Dawson
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

3.  Demonstration of a direct stimulatory effect of bile salts on rat colonic epithelial cell proliferation.

Authors:  M Barone; P Berloco; R Ladisa; E Ierardi; M L Caruso; A M Valentini; M Notarnicola; Leo A Di; A Francavilla
Journal:  Scand J Gastroenterol       Date:  2002-01       Impact factor: 2.423

4.  Prevalence of colonic motor or evacuation disorders in patients presenting with chronic nausea and vomiting evaluated by a single gastroenterologist in a tertiary referral practice.

Authors:  G J Kolar; M Camilleri; D Burton; A Nadeau; A R Zinsmeister
Journal:  Neurogastroenterol Motil       Date:  2013-10-10       Impact factor: 3.598

Review 5.  Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?

Authors:  William E Whitehead; Olafur Palsson; Kenneth R Jones
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

6.  The secretory pathway Ca2+/Mn2+-ATPase 2 is a Golgi-localized pump with high affinity for Ca2+ ions.

Authors:  Jo Vanoevelen; Leonard Dode; Kurt Van Baelen; Rebecca J Fairclough; Ludwig Missiaen; Luc Raeymaekers; Frank Wuytack
Journal:  J Biol Chem       Date:  2005-04-14       Impact factor: 5.157

7.  Bile acid malabsorption in patients with chronic diarrhoea: clinical value of SeHCAT test.

Authors:  S Wildt; S Nørby Rasmussen; J Lysgård Madsen; J J Rumessen
Journal:  Scand J Gastroenterol       Date:  2003-08       Impact factor: 2.423

8.  75Se HCAT test in the detection of bile acid malabsorption in functional diarrhoea and its correlation with small bowel transit.

Authors:  G Sciarretta; G Fagioli; A Furno; G Vicini; L Cecchetti; B Grigolo; A Verri; P Malaguti
Journal:  Gut       Date:  1987-08       Impact factor: 23.059

9.  Absence of histopathological changes of ileum and colon in functional chronic diarrhea associated with bile acid malabsorption, assessed by SeHCAT test: a prospective study.

Authors:  G Sciarretta; A Furno; B Morrone; P Malaguti
Journal:  Am J Gastroenterol       Date:  1994-07       Impact factor: 10.864

10.  Bile acid malabsorption in patients with chronic diarrhoea.

Authors:  S Eusufzai
Journal:  Scand J Gastroenterol       Date:  1993-10       Impact factor: 2.423

View more
  16 in total

1.  Colonic mucosal gene expression and genotype in irritable bowel syndrome patients with normal or elevated fecal bile acid excretion.

Authors:  Michael Camilleri; Paula Carlson; Andres Acosta; Irene Busciglio
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-04-30       Impact factor: 4.052

Review 2.  Intestinal Absorption of Bile Acids in Health and Disease.

Authors:  Alexander L Ticho; Pooja Malhotra; Pradeep K Dudeja; Ravinder K Gill; Waddah A Alrefai
Journal:  Compr Physiol       Date:  2019-12-18       Impact factor: 9.090

3.  Chronic diarrhea, bile acids, and Clostridia.

Authors:  Julian Rf Walters; Julian R Marchesi
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

Review 4.  Therapeutic targeting of bile acids.

Authors:  Michael Camilleri; Gregory J Gores
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-07-02       Impact factor: 4.052

5.  Contributions of bile acids to gastrointestinal physiology as receptor agonists and modifiers of ion channels.

Authors:  Stephen J Keely; Andreacarola Urso; Alexandr V Ilyaskin; Christoph Korbmacher; Nigel W Bunnett; Daniel P Poole; Simona E Carbone
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-11-10       Impact factor: 4.052

Review 6.  Bile Acid Diarrhea in Adults and Adolescents.

Authors:  Michael Camilleri; Samuel Nurko
Journal:  Neurogastroenterol Motil       Date:  2021-11-09       Impact factor: 3.598

7.  New and Emerging Treatment Options for Irritable Bowel Syndrome.

Authors:  Brian E Lacy; William D Chey; Anthony J Lembo
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-04

Review 8.  New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists.

Authors:  Amy E Foxx-Orenstein
Journal:  Therap Adv Gastroenterol       Date:  2016-02-21       Impact factor: 4.409

Review 9.  Elobixibat and its potential role in chronic idiopathic constipation.

Authors:  Andres Acosta; Michael Camilleri
Journal:  Therap Adv Gastroenterol       Date:  2014-07       Impact factor: 4.409

Review 10.  Update on Bile Acid Malabsorption: Finally Ready for Prime Time?

Authors:  Priya Vijayvargiya; Michael Camilleri
Journal:  Curr Gastroenterol Rep       Date:  2018-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.